Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 1 / 6 Announcement Summary Entity name ARGENT BIOPHARMA LIMITED Announcement Type New announcement Date of this announcement 11/8/2026 The Proposed issue is: Total number of +securities proposed to be...
Proposed issue of securities - RGT
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- $250,000 in Funding Received under Financing Facility
- US Veterinary Development Programme for CannEpil Commences
- Notification of cessation of securities - RGT
- CannEpil Global Licence Expands into Veterinary Healthcare
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from Argent Biopharma
- FDA-CVM Establish INAD File for CannEpil Veterinary Program
- Appendix 4G and Corporate Governance Statement
- Appendix 4E and 2026 Annual Report
- Argent Signs NLC Licence to Expand Antiviral Portfolio
- Execution of Loan Facility Agreement
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma